申请人:ARCUS BIOSCIENCES, INC.
公开号:US20210101880A1
公开(公告)日:2021-04-08
Compound that is an inhibitor of at least one of the A
2A
and A
2B
adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A
2A
receptor and/or the adenosine A
2B
receptor.